Antimicrobial
Resistance
AMR Research Bringing together genomics, microbiology, and epidemiology to investigate how antimicrobial resistance emerges and spreads — protecting the effectiveness of life-saving medicines across Africa and globally.
What the Team
Investigates
Sequencing resistant pathogens to track the emergence, spread, and evolution of AMR genes across health systems and communities.
Developing computational tools and dashboards to monitor AMR trends, visualise resistance patterns, and support real-time surveillance.
Characterising resistant isolates through laboratory-based phenotypic testing to complement and validate genomic findings.
Investigating resistance at the human-animal-environment interface to understand cross-species transmission and environmental reservoirs.
Generating evidence to support national AMR action plans, antibiotic stewardship programmes, and health system strengthening.
Partnering with African health ministries, WHO, and international networks to build continent-wide AMR surveillance capacity.
From Sample
to Policy
Clinical, environmental, and animal samples collected through surveillance networks and health facility partnerships.
Culture, susceptibility testing, and MIC profiling to characterise resistance patterns phenotypically.
Whole genome sequencing to identify resistance genes, mobile elements, and phylogenetic relationships.
AMR gene detection, plasmid typing, and phylogenomic analysis using validated computational pipelines.
Findings translated into publications, surveillance reports, and actionable policy recommendations.
Organisms Under
Surveillance
Research &
Partner Network
Developing and running AMR gene detection pipelines and genomic analysis workflows.
Performing culture, susceptibility testing, and sequencing of clinical and environmental isolates.
Contributing data to continental AMR surveillance platforms including WHO GLASS.
Partnering with national health departments to implement AMR action plans and stewardship programmes.
Meet the
Team
Latest
Publications
Emerging Infectious Diseases 31(6):. doi: 10.3201/eid3106.240930.
Microbiology Spectrum doi: 10.1128/spectrum.01466-24.